Patents by Inventor Ki Wook OH

Ki Wook OH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for determining a rapid progression rate of amyotrophic lateral sclerosis (ALS) and restoring phagocytic function of microglia thereof using a NCK-associated protein 1 (NCKAP1) protein or an mRNA thereof
    Patent number: 11958885
    Abstract: The present invention relates to a novel use of NCKAP1 gene in neurodegenerative diseases. More specifically, the present invention relates to a marker composition for predicting the prognosis of a neurodegenerative disease, comprising a NCKAP1 protein or a gene encoding same, a composition and a kit for predicting the prognosis of a neurodegenerative disease, which comprises a formulation for measuring the level of the protein or an mRNA of the gene encoding same, and a pharmaceutical composition for preventing or treating neurodegenerative disease, comprising the protein or the gene encoding same as an active ingredient.
    Type: Grant
    Filed: August 23, 2018
    Date of Patent: April 16, 2024
    Assignee: Industry-University Cooperation Foundation Hanyang University
    Inventors: Seung Hyun Kim, Min Young Noh, Min Soo Kwon, Ki Wook Oh, Min Yeop Nahm, Soo Jung Lee
  • PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NEURODEGENERATIVE DISEASE COMPRISING NCKAP1 PROTEIN OR GENE ENCODING SAME
    Publication number: 20200247854
    Abstract: The present invention relates to a novel use of NCKAP1 gene in neurodegenerative diseases. More specifically, the present invention relates to a marker composition for predicting the prognosis of a neurodegenerative disease, comprising a NCKAP1 protein or a gene encoding same, a composition and a kit for predicting the prognosis of a neurodegenerative disease, which comprises a formulation for measuring the level of the protein or an mRNA of the gene encoding same, and a pharmaceutical composition for preventing or treating neurodegenerative disease, comprising the protein or the gene encoding same as an active ingredient.
    Type: Application
    Filed: August 23, 2018
    Publication date: August 6, 2020
    Applicant: Industry-University Cooperation Foundation Hanyang University
    Inventors: Seung Hyun KIM, Min Young NOH, Min Soo KWON, Ki Wook OH, Min Yeop NAHM, Soo Jung LEE